Obesity QD Clinics Part Two

Save

Dr. Richard Conway Bariatric Surgery 'Curing' Arthritis?: https://youtu.be/W2-0RkyGqcc Dr. David Liew Managing Muscle and Fat Loss with GLP-1s: https://youtu.be/fLCDLuJGyPA Daric Mueller (PA-C) GLP-1s and History of Thyroid Cancer?:https://youtu.be/H_UlthPGN6Y Dr.

Early RA Referral Clinics Work (9.18.2026)

Save

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com

Obesity QD Clinics Part One

Save

Dr. Antoni Chan The Weight Behind the Delay in Diagnosis: https://youtu.be/-gxaFidWRw0 Dr. Mrinalini Dey Obesity: Escalate or Reassess?: https://youtu.be/Y6f_Qt5snMI Dr. Michael Putman Managing Obesity: By PCP or Rheumatologist?: https://youtu.be/zASyKJECfiM

Obesity & Inflammation: Understanding the Impact on Rheumatic Disease

Save

Explore the complex relationship between obesity, inflammation, and rheumatic disease—and how excess adiposity may influence disease development, severity, treatment response, and patient outcomes. In this expert-led discussion, leading clinicians and researchers examine how obesity can accelerate inflammatory and autoimmune rheumatic disease through metabolic, biomechanical, and immunologic pathways. The panel explores the biology of adipose t

A Day of Infamy (9.11.2026)

Save

Dr. Jack Cush reviews the news and journal reports from this past week on Rheumnow.com - including obesity, disappointing durability with GLP-1 drugs, AI diagnoses and worries about CV risk in ANCA-associated vasculitis.

Obesity Journal Club

Save

The Obesity Journal Club explores the TOGETHER PsA and STEP 9 trials and what emerging evidence tells us about the relationship between obesity, weight loss, and rheumatic disease. Authors of the papers and experts will discuss the results of these trials, discuss how we consider obesity as both a comorbidity and part of the disease course, and share practical strategies for addressing obesity in everyday rheumatology practice. Speakers: Dr.

Treating Obesity is Disease-Modifying (9.4.2026)

Save

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com. New drugs approved, new drugs halted and some drugs out of control.

A Day in the Life of a Rheumatology APP: A Focus on Interstitial Lung Disease” (hosted by Amanda Mixon, PA-C)

Save

Join Amanda Mixon, PA-C, for a practical look at the role of the rheumatology advanced practice provider (APP) in recognizing and managing interstitial lung disease (ILD). Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

DERM on RheumNow PODCAST (August 2026)

Save

The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, CTD skin disorders. dermatology drugs, biologics, andJAK inhibitors - their use, efficacy and side effects. Features Dr.

NME: New Molecular Entities (8.28.2026)

Save

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com

Label update: Structural damage progression in active PsA

Save

Listen to Dr. Catherine Bakewell’s review of clinical data from a recent label update. Sponsored by Johnson & Johnson Medical Affairs

Rheum Scholarship (8.21.2026)

Save

Dr. Cush reviews the news and journal articles from this past week on RheumNow.com; talking about lumbar belts, scholarships and misdiagnosis.

Doubting RS3PE (8.14.2026)

Save

Dr. Jack Cush reviews the news and journal articles this week where RheumNow featured info on cancer, deadly viruses, AI rules, poetry and good moons rising.

Mentshlichkeit (8.7.2026)

Save

Dr. Jack Cush reviews the news and recent journal reports on RheumNow.com

A JAKi After TNFi Failure in RA: SELECT-SWITCH at Week 12

Save

Dr. Christina Charles-Schoeman and Dr. Manish Jain are back to discuss treatment considerations after TNFi failure in RA. Join them as they review the latest data from SELECT-SWITCH, including post hoc results in primary and secondary nonresponders presented at EULAR 2026. Learn how those findings impact their clinical decision-making. Sponsored by AbbVie Medical Affairs + Health Impact